138 related articles for article (PubMed ID: 9809469)
1. Contractility and inhibition of protein phosphatases by cantharidin.
Knapp J; Bokník P; Huke S; Gombosová I; Linck B; Lüss H; Müller FU; Müller T; Nacke P; Schmitz W; Vahlensieck U; Neumann J
Gen Pharmacol; 1998 Nov; 31(5):729-33. PubMed ID: 9809469
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of action of cantharidin in smooth muscle.
Knapp J; Bokník P; Huke S; Lüss H; Müller FU; Müller T; Nacke P; Schmitz W; Vahlensieck U; Neumann J
Br J Pharmacol; 1998 Mar; 123(5):911-9. PubMed ID: 9535020
[TBL] [Abstract][Full Text] [Related]
3. On the cardiac contractile, electrophysiological and biochemical effects of endothall, a protein phosphatase inhibitor.
Bokník P; Vahlensieck U; Huke S; Knapp J; Linck B; Lüss H; Müller FU; Neumann J; Schmitz W
Pharmacology; 2000 Jul; 61(1):43-50. PubMed ID: 10895080
[TBL] [Abstract][Full Text] [Related]
4. Cantharidin enhances norepinephrine-induced vasoconstriction in an endothelium-dependent fashion.
Knapp J; Bokník P; Linck B; Lüss H; Müller FU; Petertönjes L; Schmitz W; Neumann J
J Pharmacol Exp Ther; 2000 Aug; 294(2):620-6. PubMed ID: 10900240
[TBL] [Abstract][Full Text] [Related]
5. Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A.
Honkanen RE
FEBS Lett; 1993 Sep; 330(3):283-6. PubMed ID: 8397101
[TBL] [Abstract][Full Text] [Related]
6. The protein phosphatase inhibitor cantharidin alters vascular endothelial cell permeability.
Knapp J; Bokník P; Lüss I; Huke S; Linck B; Lüss H; Müller FU; Müller T; Nacke P; Noll T; Piper HM; Schmitz W; Vahlensieck U; Neumann J
J Pharmacol Exp Ther; 1999 Jun; 289(3):1480-6. PubMed ID: 10336542
[TBL] [Abstract][Full Text] [Related]
7. On the cardiac contractile, biochemical and electrophysiological effects of cantharidin, a phosphatase inhibitor.
Neumann J; Herzig S; Boknik P; Apel M; Kaspareit G; Schmitz W; Scholz H; Tepel M; Zimmermann N
J Pharmacol Exp Ther; 1995 Jul; 274(1):530-9. PubMed ID: 7616441
[TBL] [Abstract][Full Text] [Related]
8. Endothall thioanhydride inhibits protein phosphatases-1 and -2A in vivo.
Erdödi F; Tóth B; Hirano K; Hirano M; Hartshorne DJ; Gergely P
Am J Physiol; 1995 Nov; 269(5 Pt 1):C1176-84. PubMed ID: 7491907
[TBL] [Abstract][Full Text] [Related]
9. Cantharidin impedes the activity of protein serine/threonine phosphatase in Plutella xylostella.
Chen X; Liu J; Zhang Y
Mol Biosyst; 2014 Feb; 10(2):240-50. PubMed ID: 24253262
[TBL] [Abstract][Full Text] [Related]
10. Cantharidin-binding protein: identification as protein phosphatase 2A.
Li YM; Casida JE
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11867-70. PubMed ID: 1334551
[TBL] [Abstract][Full Text] [Related]
11. The effect of the protein phosphatases inhibitor cantharidin on beta-adrenoceptor-mediated vasorelaxation.
Knapp J; Bokník P; Linck B; Lüss H; Müller FU; Nacke P; Neumann J; Vahlensieck U; Schmitz W
Br J Pharmacol; 1997 Feb; 120(3):421-8. PubMed ID: 9031745
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin.
Bertini I; Calderone V; Fragai M; Luchinat C; Talluri E
J Med Chem; 2009 Aug; 52(15):4838-43. PubMed ID: 19601647
[TBL] [Abstract][Full Text] [Related]
13. Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues.
Li YM; Mackintosh C; Casida JE
Biochem Pharmacol; 1993 Oct; 46(8):1435-43. PubMed ID: 8240393
[TBL] [Abstract][Full Text] [Related]
14. Expression and functional role of serine/threonine phosphatases in rat esophagus.
van der Voort IR; Knapp J; Konturek JW; Boknik P; Domschke W; Schmitz W; Neumann J
Med Sci Monit; 2004 May; 10(5):BR123-9. PubMed ID: 15114259
[TBL] [Abstract][Full Text] [Related]
15. Calcium-independent activation of the contractile apparatus in smooth muscle of mouse aorta by protein phosphatase inhibition.
Knapp J; Aleth S; Balzer F; Schmitz W; Neumann J
Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):562-9. PubMed ID: 12444498
[TBL] [Abstract][Full Text] [Related]
16. Role of protein phosphatases in regulation of cardiac inotropy and relaxation.
Bokník P; Khorchidi S; Bodor GS; Huke S; Knapp J; Linck B; Lüss H; Müller FU; Schmitz W; Neumann J
Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H786-94. PubMed ID: 11158978
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of serine/threonine phosphoprotein phosphatases alter circadian properties in Gonyaulax polyedra.
Comolli J; Taylor W; Rehman J; Hastings JW
Plant Physiol; 1996 May; 111(1):285-91. PubMed ID: 8685268
[TBL] [Abstract][Full Text] [Related]
18. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
Sakoff JA; Howitt IJ; Ackland SP; McCluskey A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):225-32. PubMed ID: 14648018
[TBL] [Abstract][Full Text] [Related]
19. Protein phosphatase inhibitor cantharidin inhibits steroidogenesis and steroidogenic acute regulatory protein expression in cultured rat preovulatory follicles.
Yu CC; Chen WY; Li PS
Life Sci; 2001 Nov; 70(1):57-72. PubMed ID: 11764007
[TBL] [Abstract][Full Text] [Related]
20. Effect of 2,3-butanedione monoxime on force of contraction and protein phosphorylation in bovine smooth muscle.
Waurick R; Knapp J; Van Aken H; Bokník P; Neumann J; Schmitz W
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):484-92. PubMed ID: 10431760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
